催产素市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按适应症(产前和产后)、分销渠道(医院药房、药店和在线药房)和地理位置进行细分。

市场快照

OXT
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,研究的催产素市场预计复合年增长率接近 5.4%。

· 推动市场增长的某些因素包括妊娠并发症发病率的增加、全球出生人数的增加以及对引产和母乳喂养的认识不断提高。

· 可支配收入的增加,特别是发展中国家的可支配收入的增加,妇女对孕期保健产品的认识提高,妇女识字率的提高以及催产素产品的发达分销渠道的增加是推动催产素市场增长的主要因素。

然而,严格的法规和催产素药物的高成本预计将成为妊娠产品市场增长的关键制约因素。

报告范围

该报告涵盖了使用催产素的商业产品,催产素是一种在大脑中制造的激素,通过引起子宫(子宫)和乳房乳腺的肌肉收缩,在分娩和哺乳中发挥作用。

By Indication
Antepartum
Postpartum
By Distribution Channel
Hospital Pharmacies
Drug Stores
Online Pharmacies
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

产前在催产素市场占有重要份额

产前催产素注射液(合成)适用于启动或改善子宫收缩,因为胎儿或母体原因需要并被认为适合实现早期阴道分娩。在产前,外源性催产素经 FDA 批准用于加强子宫收缩,目的是成功阴道分娩。

seg 2 oxt.png

北美主导催产素市场

由于对怀孕产品的高度认识和个人护理产品支出的增加,北美在催产素产品市场上占据主导地位。然而,由于中国和印度等发展中经济体可支配收入的增加、完善的分销渠道的增加以及对催产素的认识不断提高等因素,预计亚太地区在预测期内将大幅增长通过主要参与者的强大营销活动来生产产品。

geo oxt.PNG

竞争格局

催产素市场竞争激烈,由几个主要参与者组成。Bimeda、GlaxoSmithKline PLC、Grindeks、JHP Pharmaceuticals、KAPL、Novartis AG、辉瑞公司和上海和丰等公司在市场上占有相当大的份额。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Pregnancy Complications

      2. 4.2.2 Rising Number of Births Globally

      3. 4.2.3 Growing Awareness of Induced Labor and Breastfeeding

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 High Cost of Oxytocin Drug

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Indication

      1. 5.1.1 Antepartum

      2. 5.1.2 Postpartum

    2. 5.2 By Distribution Channel

      1. 5.2.1 Hospital Pharmacies

      2. 5.2.2 Drug Stores

      3. 5.2.3 Online Pharmacies

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bimeda

      2. 6.1.2 GlaxoSmithKline PLC

      3. 6.1.3 Grindeks

      4. 6.1.4 JHP Pharmaceuticals

      5. 6.1.5 KAPL

      6. 6.1.6 Novartis AG

      7. 6.1.7 Pfizer Inc.

      8. 6.1.8 Shanghai Hefeng

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Oxytocin Market market is studied from 2018 - 2026.

The Oxytocin Market is growing at a CAGR of 5.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Pfizer Inc. , Novartis AG , GlaxoSmithKline PLC, Grindeks, KAPL are the major companies operating in Oxytocin Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!